Article
High prevalence of pre-treatment HIV drug resistance in Papua New Guinea: findings from the first nationally representative pre-treatment HIV drug resistance study.
BMC infectious diseases - 19 Mar 2022
Gare Janet, Toto Ben, Pokeya Percy, Le Linh-Vi, Dala Nick, Lote Namarola, John Bangan, Yamba Abel, Soli Kevin, DeVos Joshua, Paulin Heather, Wagar Nick, Zheng Du-Ping, Nishijima Takeshi, Boas Peniel, Kelly-Hanku Angela, Gurung Anup
Abstract excerpt
BACKGROUND: Determining the prevalence of pre-treatment HIV drug resistance (PDR) is important to assess the effectiveness of first-line therapies. To determine PDR prevalence in Papua New Guinea (PNG), we conducted a nationally representative survey. METHODS: We used a two-stage cluster sampling method to recruit HIV treatment initiators with and without prior exposure to antiretroviral therapies (ART) in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.